Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)

44 plaintiff states filed suit against Teva Pharmaceuticals and 19 of the nation’s largest generic drug manufacturers alleging a broad conspiracy to artificially inflate and manipulate prices, reduce competition and unreasonably restrain trade for more than 100 different generic drugs. The lawsuit was originally Connecticut, was transferred to the MDL court in Pennsylvania.  The lawsuit…

Read More →

Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)

Plaintiff states filed a third lawsuit stemming from the ongoing antitrust investigation into a widespread conspiracy by generic drug manufacturers to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for generic drugs sold across the United States. The complaint focuses on 80 topical generic drugs  and names 26 corporate Defendants and 10…

Read More →

People of California v. Vitol, Inc. et al., (Cal. Super. Ct. (San Francisco Cty.)

Plaintiff state sued two gasoline trading firms, Vitol Inc. and SK Energy Americas, alleging that they took advantage of market disruptions from a 2015 refinery explosion in Torrance to improperly drive up the gasoline prices. The state sought an injunction, damages, restitution, and civil penalties. The complaint alleged that the two companies made manipulative trades…

Read More →

Washington v. Tyson Foods, Inc., No. 21-2-14174-5 (Wash. Super. Ct. King Cty. 2022)

Plaintiff state filed a lawsuit against 19 chicken producers accusing them of a wide-ranging illegal conspiracy to inflate and manipulate prices, rig contract bids and coordinate industry supply reductions to maximize profits. The defendants account for approximately 95 percent of the broiler chickens sold in the United States. The complaint asserts their conduct violates the…

Read More →

Utah et al. v. Google LLC, No. 3:21-cv-05227 (N.D. Cal. July 7, 2021)

Thirty-seven states filed a lawsuit against Google for monopolizing the smartphone application market in violation of state and federal antitrust laws. According to the complaint, Google operates a web of exclusionary agreements with phone manufacturers and carriers to exert control over app distribution on Android phones through its Google Play Store. By leveraging those anticompetitive…

Read More →

Illinois v. Elite Staffing, No. 2020CH05156 (Cir. Ct. Cook Cty. Ill. July 29, 2020)

Plaintiff state sued staffing agencies Elite Staffing, Inc. (Elite), Metro Staff, Inc. (Metro) and Midway Staffing, Inc. (Midway), as well as their client Colony, Inc. (Colony). The complaint alleged that the three staffing agencies formed an unlawful agreement to refuse to solicit or hire the other’s employees and to fix the wages paid to their…

Read More →

FTC et al. v. Vyera Pharmaceuticals, No. 1:20-cv-00706 (S.D.N.Y. Apr. 19, 2020)

The FTC, New York and six other states filed suit against Vyera Pharmaceuticals, its parent company, Phoenixus and its former officers, Kevin Mulleady and Martin Shkreli, alleging anticompetivie conduct in connection with Daraprim, the only FDA approved drug for the treatment of the life-threatening parasitic disease toxoplasmosis.  The suit alleges that Vyera purchases the unpatented…

Read More →

Connecticut v. Marsh & McLennan Companies et al., , No. X05-CV-05-4004360-S (Ct. Super. Ct. 2009)

Plaintiff state originially sued insurance carrier ACE, alleging kickbacks from ACE to Marsh. See In the Matter of ACE Ltd. and ACE Group Holdings, Inc. The state later expanded the lawsuit against Marsh, alleging that, when Marsh customers wanted to purchase insurance or renew insurance they already had, Marsh brokers frequently decided which insurer should be given the business and at what price. Marsh’s quote for insurance was typically a substantial increase — as much as 15 to 20 percent — over the previous year’s price.

Read More →

California v. TRW, No. 2:18-cv-13286 (E.D. Mich.) filed 10/22/18

State alleged, as part of multidistrict litigation of antitrust claims against auto parts manufacturers, that TRW conspired with other parts manufacturers to rig bids for, fix and maintain the price of Occupant Safety Restraing Systems, installed in cars purchased by the state.State alleged violations of Sherman Act sec. 1 and the Cartwright Act (Cal Bus. & Prof. Code sec. 16720) and California’s Unfair Competition Law (Cal. Bus. & Prof. Cod sec. 17200). State sought damages and “deadweight loss” (gneeral damage to state) and disgorgement. Settlement was $122,500. TRW agreed to cooperate fully with the state in investigating other participants in the conspiracy.

Read More →

Florida v. General Chemical Corp. No. 2:17-00384 (D.N.J. Jan. 19, 2017)

Plaintiff state filed action in federal court alleging market allocation and price-fixing among manufacturers of the chemical liquid aluminum sulfate, which is a coagulant used to remove impurities and other substances from water. It is used primarily by municipalities in wastewater treatment. There are high barriers to entry and substitution is difficult. There have been several USDOJ indictments in the industry. The complaint alleged that the defendants conspired to circumvent competitive bidding and independent pricing and to raise liquid aluminum sulfate prices by submitting artificially inflated bids in Florida from 1997 through at least February 2012. The state alleged that fraudulent concealment of the conspiracy tolled the statute of limitations.

Read More →